| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 9 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 9 |
| 2 | TACROLIMUS OINTMENT 0.1% | 9 |
| 3 | PREDNISOLONE | 7 |
| 4 | PREDNISOLONE ORAL | 7 |
| 5 | PREDNISOLONE ORAL SOLUTION | 7 |
| 6 | DABIGATRAN ETEXILATE | 5 |
| 7 | DUTASTERIDE | 5 |
| 8 | IMATINIB | 5 |
| 9 | PREDNISONE | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DEMECLOCYCLINE | 1 | 0.0044 |
| 1 | BUPIVACAINE HYDROCHLORIDE WITH DEXTROSE | 1 | 0.0022 |
| 2 | IDARUCIZUMAB | 1 | 0.0007 |
| 3 | DUTASTERIDE | 5 | 0.0006 |
| 4 | ROPIVACAINE HYDROCHLORIDE | 1 | 0.0004 |
| 5 | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE | 3 | 0.0004 |
| 6 | BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | 1 | 0.0003 |
| 7 | BUPIVACAINE | 3 | 0.0003 |
| 8 | SOTALOL HYDROCHLORIDE | 5 | 0.0003 |
| 9 | CEFUROXIME AXETIL | 1 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Humanized Monoclonal Antibody Fragment [EPC] | 1 | 0.0007 |
| 1 | CD38-directed Cytolytic Antibody [EPC] | 2 | 0.0003 |
| 2 | Glinide [EPC] | 2 | 0.0002 |
| 3 | Lipid-based Polyene Antifungal [EPC] | 1 | 0.0001 |
| 4 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 5 | 5-alpha Reductase Inhibitor [EPC] | 5 | 0.0000 |
| 6 | Antimetabolite Immunosuppressant [EPC] | 1 | 0.0000 |
| 7 | Catecholamine [EPC] | 3 | 0.0000 |
| 8 | Amide Local Anesthetic [EPC] | 3 | 0.0000 |
| 9 | Penem Antibacterial [EPC] | 1 | 0.0000 |